Medical Condition News

RSS

20% of returning war veterans report PTSD or major depression

This past Memorial Day honored those Americans who have died in military service including over 4,000 in Iraq and 1,000 fallen soldiers in Afghanistan. According to the latest Pentagon study, released in April this year, nearly 20 percent—or one in five returning war veterans—reported symptoms of post-traumatic stress disorder (PTSD) or major depression. The study also reports that approximately half of them sought treatment.

4 Jun 2010

Key regulator of fat cell differentiation identified

New research led by UCD Conway Fellow, Professor Johan Ericsson has identified a key regulator of fat cell differentiation that may be a novel target for obesity drugs. The results of the research are published in the current edition of the scientific journal, Proceedings of the National Academy of Sciences (PNAS).

4 Jun 2010

NICE recommends minimum price for alcohol and ban on alcohol advertising

The government should introduce a minimum price for alcohol and consider an outright ban on alcohol advertising, the National Institute for Health and Clinical Excellence (NICE) has said.

4 Jun 2010

Researchers identify region of DNA that may contain gene linked to progression, spread of bowel cancer

Scientists have identified a region of DNA that appears to be involved in the development of pre-cancerous bowel growths (polyps) and that may contain a gene involved in the progression of bowel cancer.

4 Jun 2010

Research finding suggests possibilities for future treatment of anxiety disorders

Researchers at the University of Puerto Rico, School of Medicine have found a way to pharmacologically induce a memory of safety in the brain of rats. As reported in the June, 4 2010 issue of Science, administering brain-derived neurotrophic factor into the prefrontal cortex prevented rats from expressing fear to a tone that had been previously paired with a shock.

4 Jun 2010

ELLICSR research centre opened at UHN

What do you get when you combine a comedian, a magician, a radio show host, and a chef? A group of cancer survivors and caregivers celebrating National Cancer Survivors Day at the opening of a unique new research centre at University Health Network (UHN), the first of its kind in Canada.

4 Jun 2010

Hiru, MindUp BioResearch comment on recent research findings in cancer treatments

Hiru Corporation and its European subsidiary MindUp BioResearch comment on the recent research findings in the field of cancer treatments for multi-drug resistant non-small cell lung cancer.

4 Jun 2010

R-Tech Ueno announces completion of Phase II clinical study of UF-021 for retinitis pigmentosa

We are pleased to announce that the Phase II clinical study of UF-021, product name Ocuseva, which we are developing as a therapeutic drug for retinitis pigmentosa, has been completed.

4 Jun 2010

American Cancer Society and NPCRC award $1.8M for palliative care research

The American Cancer Society and the National Palliative Care Research Center (NPCRC) are awarding $1.8 million in research grants to researchers at 12 institutions for studies aimed at reducing suffering for seriously ill patients and their family caregivers. The studies will be conducted over the next two years. Since 2007, a collaborative effort by the organizations has awarded 51 grants totaling almost $7 million.

4 Jun 2010

Special dementia care plan does not slow functional decline compared with usual care: Study

A special dementia care plan, involving regular assessments of patients with Alzheimer's disease in specialist memory clinics, does not slow functional decline compared with usual care, finds a study published on bmj.com today.

4 Jun 2010

ASGE issues guidelines on ethnicity, gastrointestinal diseases and endoscopic procedures

The American Society for Gastrointestinal Endoscopy (ASGE) has issued guidelines addressing ethnicity, gastrointestinal diseases and endoscopic procedures. The guideline suggests that colorectal cancer screening should begin at age 45 for average risk African-American men and women, and that it is recommended that colorectal cancer screening be emphasized for other minority ethnic groups that have lower screening utilization rates.

4 Jun 2010

ViiV Healthcare to provide additional cost savings to cash-strapped ADAPs

AHF is pleased to report that yet another drug company: ViiV Healthcare, a new drug company formed in a partnership between GSK and Pfizer, has announced an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide.

4 Jun 2010

Latest version of LOINC for electronic health information exchange to be released

As the practice, regulation and reimbursement of health care become more complicated, and as the demand for electronic medical records and health information exchange grows, a universal method of identifying test results and other clinical measurement is essential.

4 Jun 2010

WisTa Laboratories announces collaborative R&D agreement with Bayer Schering Pharma

WisTa Laboratories Ltd, a wholly owned subsidiary of TauRx Pharmaceuticals, announced today that they have entered a collaborative R&D agreement with Bayer Schering Pharma AG, Germany, which could redefine the way Alzheimer's disease (AD) and related disorders are currently being diagnosed and treated.

4 Jun 2010

SERCA2a gene therapy proves effective in people with advanced heart failure: Researchers

Researchers at Mount Sinai School of Medicine have developed a new gene therapy that is safe and effective in reversing advanced heart failure. SERCA2a (produced as MYDICAR-) is a gene therapy designed to stimulate production of an enzyme that enables the failing heart to pump more effectively.

4 Jun 2010

Early detection and removal of pancreatic cysts may lower cancer risk: Researchers

Working with researchers from the University of Michigan and Indiana University, Van Andel Research Institute investigators have developed a method that could be used to predict whether pancreatic cysts are benign or are precursors to invasive cancer.

4 Jun 2010

Tioga commences dosing in Phase 3 trial of asimadoline for diarrhea-predominant irritable bowel syndrome

Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.

4 Jun 2010

Unhealthy diet and lifestyle linked to childhood asthma - study

Asthma in children is on the rise worldwide and scientists have often blamed the environment for this trend. Britain has more than 1.1 million children and the US has nearly 10 million children with asthma. In a new international study diet has been cited to be a factor that affects asthma in children. The study on Allergies and Asthma in Childhood has shown what many parents knew for a while now – burgers are not good for children.

3 Jun 2010

New autism early intervention centers promised for Mackay and Bundaberg

The Queensland Government has announced $1 million a year over three years for new autism centers in Bundaberg and Mackay. These will provide care and also early intervention services to the substantial number of autistic children in the region.

3 Jun 2010

Over 90% of psychiatric patients treated in community hospitals are cared for in specialty units: Study

Over 90 percent of psychiatric patients who received treatment in community hospitals were cared for in hospital-based psychiatric specialty units, according to a study sponsored by the Substance Abuse and Mental Health Services Administration and the U.S. Agency for Healthcare Research and Quality and published today in Psychiatric Services.

3 Jun 2010

Medical Condition News

20% of returning war veterans report PTSD or major depression

Key regulator of fat cell differentiation identified

NICE recommends minimum price for alcohol and ban on alcohol advertising

Researchers identify region of DNA that may contain gene linked to progression, spread of bowel cancer

Research finding suggests possibilities for future treatment of anxiety disorders

ELLICSR research centre opened at UHN

Hiru, MindUp BioResearch comment on recent research findings in cancer treatments

R-Tech Ueno announces completion of Phase II clinical study of UF-021 for retinitis pigmentosa

American Cancer Society and NPCRC award $1.8M for palliative care research

Special dementia care plan does not slow functional decline compared with usual care: Study

ASGE issues guidelines on ethnicity, gastrointestinal diseases and endoscopic procedures

ViiV Healthcare to provide additional cost savings to cash-strapped ADAPs

Latest version of LOINC for electronic health information exchange to be released

WisTa Laboratories announces collaborative R&D agreement with Bayer Schering Pharma

SERCA2a gene therapy proves effective in people with advanced heart failure: Researchers

Early detection and removal of pancreatic cysts may lower cancer risk: Researchers

Tioga commences dosing in Phase 3 trial of asimadoline for diarrhea-predominant irritable bowel syndrome

Unhealthy diet and lifestyle linked to childhood asthma - study

New autism early intervention centers promised for Mackay and Bundaberg

Over 90% of psychiatric patients treated in community hospitals are cared for in specialty units: Study

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News